Follow-up study for birdshot eye inflammation
Part of Eyes & vision, Immune system & allergy clinical trials.
This study follows people with “birdshot chorioretinopathy,” a rare eye inflammation, and collects immune (genetic) information to better understand the disease. You may benefit from closer monitoring, and the results may help guide future treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have birdshot eye inflammation in both eyes (bilateral disease).
- In at least one eye, your eye exam shows three or more birdshot lesions near the optic nerve, on the lower or inner (nasal) side.
- Your eye inflammation in the front of the eye is mild (no more than 1+ cells).
- Your eye inflammation inside the eye is mild (no more than 2+ vitreous haze).
- You do not have other conditions that could explain similar eye findings (like infection, cancer, or a different inflammatory eye disease).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is looking for biomarkers (clues in your body) related to abnormal blood vessels in the eye. It may help researchers understand and treat conditions like macular degeneration.
This study looks for new ways to diagnose and track eye disorders using imaging and genetic tests. It may help find better treatments for conditions linked to blood vessel and nerve problems in the eye.
This study uses a special eye scan (OCT) to measure and classify inflammatory cells inside the eye. It aims to better understand different types of uveitis and improve diagnosis and treatment.
This study follows people with non-infectious uveitis (inflammation inside the eye) that affects the middle or back of the eye. It aims to understand the disease better and see how different treatments work, which may help improve future care.
This study is building a detailed database of images and information from people with various eye diseases, especially those involving inflammation or swelling. Researchers will use advanced cameras and tests to better understand these conditions and potentially improve treatments.
This study looks at substances (“biomarkers”) in the clear fluid inside the eye to better understand several eye conditions that affect vision. Your results may help doctors learn how these diseases work and how treatments might be chosen.
Hear when a new Birdshot Chorioretinopathy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.